# FDA drug recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL

> recall · VERIFIED · 2026-04-24

Firm: Teva Pharmaceuticals USA, Inc · Class II · Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

- Company: Teva Pharmaceuticals USA, Inc
- Sector: pharma
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.